Evidence map›Paper›PMID 35683476›Full record

ReviewJournal of clinical medicine2022

Evolving Indications of Transcatheter Aortic Valve Replacement-Where Are We Now, and Where Are We Going.

Jules Mesnier, Vassili Panagides, Jorge Nuche, Josep Rodés-Cabau

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Observational
  10. Article
  11. Article
  12. Demographics and outcomes of patients younger than 75 years undergoing aortic valve interventions in Rotterdam.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Transcatheter Aortic Valve Implantation Two Decades of Evolution - TAVI From Current Perspective.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jules MesnierQuebec Heart and Lung Institute, Laval University, Quebec City, QC G1V 4G5, Canada.ORCID 0000-0002-2131-6763
Vassili PanagidesQuebec Heart and Lung Institute, Laval University, Quebec City, QC G1V 4G5, Canada.ORCID 0000-0002-0012-1289
Jorge NucheQuebec Heart and Lung Institute, Laval University, Quebec City, QC G1V 4G5, Canada.ORCID 0000-0002-8269-2244
Josep Rodés-CabauQuebec Heart and Lung Institute, Laval University, Quebec City, QC G1V 4G5, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Indications for transcatheter aortic valve replacement (TAVR) have steadily increased over the last decade since the first trials including inoperable or very high risk patients. Thus, TAVR is now the most common treatment of aortic valve stenosis in elderly patients (vs. surgical aortic valve replacement -SAVR-). In this review, we summarize the current indications of TAVR and explore future directions in which TAVR indications can expand.

Indexed as

aortic regurgitationaortic stenosisbicuspid valvemoderate aortic stenosistranscatheter aortic valve replacement

Identifiers

PMID35683476
PMCPMC9180932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.